Novel method of applying matrine to treating eczematous dermatitis

Abstract

The invention provides a novel method of applying matrine to treating eczematous dermatitis, belonging to the field of medicines. The method is characterized by 1. adopting intravenous drip of matrine to treat eczematous dermatitis, 2. adopting intravenous drip of matrine to treat eczematous dermatitis in combination with oral administration of antihistamines, 3. adopting oral administration of matrine tablets or capsules to treat eczematous dermatitis and 4. applying matrine ointments to the wounded parts to externally treat eczematous dermatitis. Compared with the existing medicines and methods for treating eczematous dermatitis, the novel method has the effects that unexpected curative effects can be obtained and the cure rate is above 75%. The new method is an innovative idea of holistic treatment for treating eczematous dermatitis and has great medical significance.

Description

[0001] technical field

[0002] The invention belongs to the field of medicaments, in particular to the application method of matrine for treating dermatitis and eczema. Background technique

[0003] As we all know, dermatitis and eczema skin diseases are common diseases in dermatology. The etiology and pathogenesis of dermatitis and eczema are not yet clear. The etiology is quite complicated, and most of them are caused by allergies. It is an allergic reaction caused by the interaction of various internal and external factors. But some dermatitis eczema has nothing to do with allergy. Changes in patient responsiveness often involve many factors, some of which are still unclear and need to be studied in the future. (1) Genetic factors: Certain types of eczema are closely related to genetics. Eczema patients often have certain allergic constitutions, and there is a history of allergic diseases in the family. Prone to allergic diseases such as contact dermatitis and drug rea...

Examples

Embodiment 1

[0015] A total of 30 patients with eczema were selected and treated with matrine (0.15g) / d intravenously. Two weeks was a course of treatment, and the curative effect was judged after the course of treatment was over. After statistical processing, the results show that matrine has a significant effect on treating eczema, and no obvious adverse reactions have been seen.

Embodiment 2

[0017] Select 30 patients with eczema, take matrine capsules (50mg tid po), 2 weeks as a course of treatment, and judge the curative effect after the course of treatment. After statistical processing, the results show that matrine has a significant effect on treating eczema, and no obvious adverse reactions have been seen.

Embodiment 3

[0019] A total of 30 patients with eczema were selected and treated with matrine tablets (50mg tid po), 2 weeks as a course of treatment, and the curative effect was judged after the course of treatment. After statistical processing, the results show that matrine has a significant effect on treating eczema, and no obvious adverse reactions have been seen.

[0001] technical field

[0002] The invention belongs to the field of medicaments, in particular to the application method of matrine for treating dermatitis and eczema. Background technique

[0003] As we all know, dermatitis and eczema skin diseases are common diseases in dermatology. The etiology and pathogenesis of dermatitis and eczema are not yet clear. The etiology is quite complicated, and most of them are caused by allergies. It is an allergic reaction caused by the interaction of various internal and external factors. But some dermatitis eczema has nothing to do with allergy. Changes in patient responsiveness often involve many factors, some of which are still unclear and need to be studied in the future. (1) Genetic factors: Certain types of eczema are closely related to genetics. Eczema patients often have certain allergic constitutions, and there is a history of allergic diseases in the family. Prone to allergic diseases such as contact dermatitis and drug rea...

Examples

Embodiment 1

[0015] A total of 30 patients with eczema were selected and treated with matrine (0.15g) / d intravenously. Two weeks was a course of treatment, and the curative effect was judged after the course of treatment was over. After statistical processing, the results show that matrine has a significant effect on treating eczema, and no obvious adverse reactions have been seen.

Embodiment 2

[0017] Select 30 patients with eczema, take matrine capsules (50mg tid po), 2 weeks as a course of treatment, and judge the curative effect after the course of treatment. After statistical processing, the results show that matrine has a significant effect on treating eczema, and no obvious adverse reactions have been seen.

Embodiment 3

[0019] A total of 30 patients with eczema were selected and treated with matrine tablets (50mg tid po), 2 weeks as a course of treatment, and the curative effect was judged after the course of treatment. After statistical processing, the results show that matrine has a significant effect on treating eczema, and no obvious adverse reactions have been seen.